Higher doses and off-label HRT: when standard does not fit

Most women do well on standard doses of HRT. But the licensed dose is an average, and people are not averages. Some women absorb oestrogen poorly through the skin, some have an early menopause that needs fuller replacement, and some cannot tolerate the usual progesterone. For them, getting treatment right can mean adjusting beyond the standard regimen, sometimes beyond what the licence specifies. This article explains what that means and why it is a normal part of careful prescribing.

What off-label means

A medicine is licensed for particular uses and doses based on its trials. Prescribing it differently, a higher dose, a different combination, is called off-label. It sounds alarming, but it is routine in everyday medicine across many fields, and it is well established in menopause care. It does not mean experimental or unapproved. It means a doctor is using judgement and evidence to tailor a licensed medicine to a patient the standard dose does not fit. We explain what it means so the choice is yours.

When a higher oestrogen dose is needed

A proportion of women do not get symptom relief on standard transdermal doses, often because they absorb less through the skin. Rather than concluding that HRT has failed, the sensible step is to check absorption with a blood test and, if appropriate, increase the dose. In early menopause and premature ovarian insufficiency, higher doses are expected, because the aim is to replace to normal pre-menopausal levels rather than just ease symptoms.

When the progesterone needs changing

Progesterone protects the womb lining, and for women with a womb it is not optional. But some women tolerate the standard regimen poorly, with low mood, bloating or other effects. There are ways to adjust, a different schedule, a lower dose, or a progestogen-releasing coil that works locally. Where a reduced progesterone approach is used, it comes with added monitoring of the womb lining, because protecting it is the one thing that cannot be compromised.

The safeguards that make it safe

Off-label and higher-dose prescribing is safe when it is done properly, and that has a clear shape:

• A clear clinical reason, not dose escalation for its own sake.

• Monitoring that matches the change: a blood level to guide a higher oestrogen dose, extra surveillance of the womb lining where progesterone is reduced.

• An honest conversation about what off-label means and why it is being suggested, so the decision is shared.

• Regular review, because the right dose is the lowest that controls your symptoms, and that can change over time.

What we will not do

Tailoring within good clinical reasoning is one thing. Pushing hormones to levels above the natural range in pursuit of vague promises of vitality is another, and we do not do it. The evidence does not support it, and the side effects are real. Individualised does not mean limitless; it means the right dose for you, monitored.

The point

If standard HRT has not worked for you, that is often a reason to adjust rather than to give up. Done with a clear reason, the right monitoring, and an honest conversation, going beyond the standard regimen is a normal part of good menopause care, not a risk to be feared.

Read next

• body identical hrt explained

• early menopause and poi

• who should not take hrt

Ready to start?

If you want to move from reading to acting, the next step is a short assessment with a GP who has specific menopause expertise. It takes about ten minutes and tells you what will help.

Begin your assessment at this link. Online or in person at Westfield London.